Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis

Table 4 SUCRA values

a. SUCRA values for five outcomes
OS		LR		DM		POM		R0 resection
Treatment	SUCRA	Treatment	SUCRA	Treatment	SUCRA	Treatment	SUCRA	Treatment	SUCRA
nCRTS-ENI	0.93	nCRTS-IFI	0.95	nCRTS-IFI	0.69	S alone	0.83	S alone	1.00
nCRTS-IFI	0.71	nCRTS-ENI	0.62	nCRTS-ENI	0.67	nCTS	0.79	nCTS	0.67
nCTS	0.36	nCTS	0.39	nCTS	0.53	nCRTS-IFI	0.20	nCRTS-IFI	0.19
S alone	0.00	S alone	0.04	S alone	0.11	nCRTS-ENI	0.19	nCRTS-ENI	0.15
b. SUCRA values of OS for four subgroups
ESCC		EAC		RT dose		RT-technique
Treatment	SUCRA	Treatment	SUCRA	Treatment	SUCRA	Treatment	SUCRA
nCRTS-IFI	0.90	nCRTS-ENI	0.96	nCRTS-ENI- ≥ 40Gy	0.86	nCRTS-ENI-3DRT	0.98
nCRTS-ENI	0.68	nCRTS-IFI	0.63	nCRTS-IFI- ≥ 40Gy	0.75	nCRTS-IFI-3DRT	0.69
nCTS	0.34	nCTS	0.41	nCRTS-ENI- < 40Gy	0.73	nCRTS-IFI-2DRT	0.54
S alone	0.08	S alone	0.00	nCTS	0.35	nCRTS-ENI-2DRT	0.42
				nCRTS-IFI- < 40Gy	0.25	nCTS	0.34
				S alone	0.05	S alone	0.03

Abbreviations: SUCRA Surface under the cumulative ranking curve, OS Overall survival, LR Locoregional recurrence, DM Distant metastases, POM Post-operative mortality, nCRTS Neoadjuvant chemoradiotherapy plus surgery, nCTS Neoadjuvant chemotherapy plus surgery, S Surgery, RT Radiotherapy, ENI Elective nodal irradiation, IFI Involved-field irradiation, ESCC Esophagus squamous cell carcinoma, EAC Esophagus adenocarcinoma, 2D Two-dimensional, 3D Three-dimensional

ISSN: 1748-717X